ALPHA TEKNOVA, INC. Debt Instrument, Fair Value Disclosure
ALPHA TEKNOVA, INC. (TKNO) had Debt Instrument, Fair Value Disclosure of $12.10 million as of 2023-09-30, per its 10-Q filed 2023-11-13.
Discontinued › Notes › Debt › Debt Instruments
us-gaap:DebtInstrumentFairValue · last filed 2023-11-13
- 2023-09-30: Debt Instrument, Fair Value Disclosure $12.10M.
- 2023-06-30: Debt Instrument, Fair Value Disclosure $22.10M.
| Period end | Debt Instrument, Fair Value Disclosure |
|---|---|
| 2023-09-30 | $12.10M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $22.10M 10-Q · filed 2023-08-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |